Acrotech Biopharma Inc
Acrotech Biopharma Inc is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About Acrotech Biopharma Inc
Acrotech Biopharma Inc is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by IBRITUMOMAB TIUXETAN. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: follicular nhl, adult patients, relapsed refractory, previously untreated, b-cell non-hodgkin, achieve partial, complete response, first-line chemotherapy. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| IBRITUMOMAB TIUXETAN | 1 |
FDA drug products from Acrotech Biopharma Inc
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Zevalin | IBRITUMOMAB TIUXETAN | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products does Acrotech Biopharma Inc make?
1 FDA drug label records name Acrotech Biopharma Inc as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Acrotech Biopharma Inc produce?
The most frequent active ingredients in this portfolio are IBRITUMOMAB TIUXETAN.
Are Acrotech Biopharma Inc products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.